救心复脉注射液治疗心源性休克的临床研究

验证救心复脉注射液治疗心源性休克的临床疗效。方法：用ＣＡ静脉给药治疗心源性休克２０例，用多巴胺注射液作对照。结果；ＣＡ组有效１８例，无效２例，ＤＡ组有效９例，无效２例，组间比较，Ｐ〉０．０５。结论ＣＡ和ＤＡ均能升高血压，增加心泵功能，改善厥脱证的症脉，但ＣＡ比ＤＡ升压速度快，幅度高，作用稳定，对心率有双相调节作用，使心动过速患者心率减慢，使心动过缓患者心率增快。

Clinical Study of Jiuxin Fumai Injection in Treatment of Cardiogenic Shock

Objective: To increase the cure and improvement rates and to decrease the mortality rate in the treatment of cardiogenic shock. Methods: Thirty one patients with cardiogenic shock were studied, and received Jiuxin Fumai injection (JXFM) in research group (n=20) or dopamine (DA) in control group (n=11). Results: Eighteen effective cases (90.0%) and 2 ineffective cases (10.0%) in JXFM group, 9 effective cases (81.8%) and 2 ineffective cases (18.2%) in DA group. There was insignificant difference statistically, P>0 05. Conclusions: JXFM and DA had the same effect in elevating blood pressure, enhancing pump function of the heart and ameliorating collapse syndrome. They are safe, effective, convenient for use and prompt in responding. However, JXFM showed raising blood pressure faster, higher as well as more stable, and the dual phase phenomenon in adjusting heart rate, which could slow down tachycardia as well as speed up bradycardia were observed.